$ACMR

Wang David H sold $560K of ACMR

Wang David H (See Remarks) sold 6,295 shares of ACM Research, Inc. (ACMR) at $88.98 ($0.56M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

A disclosed open-market sale by an insider under a pre-arranged 10b5-1 plan is generally treated as low-signal for fundamentals; it can modestly influence sentiment if traders interpret it as risk reduction.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 structure makes it unlikely to drive a major repricing by itself.

03

What to watch

The article provides no context on total insider ownership changes beyond the post-transaction holdings, nor any concurrent operational/financial developments.

Relevance 6/10Novelty 3/10Timing: Filed after-hours (SEC EDGAR timestamp 2026-06-05 16:30 ET) for a 2026-06-03 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for ACM Research, Inc. (ACMR).

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider (officer/director/10% owner) sold 6,295 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely muted due to 10b5-1 pre-arrangement.

Evidence & confidence

Form 4 insider sales are typically informational for sentiment, but the presence of a pre-arranged 10b5-1 plan reduces the signal of new negative information.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with periods of valuation risk or liquidity needs; traders may watch for clustering across filings.

Key entities

  • ACM Research, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Wang David H

    Officer/director/10% owner who sold shares under a 10b5-1 plan.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.